Does Anthem Cover Ozempic? A Complete Insurance Guide for 2025

Print or save as PDF

Key numbers

  • 18.7%Kidney or cardiovascular composite events on Ozempic 1 mg in adults with type 2 diabetes and CKD (FLOW trial)Source: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 6.6%Cardiovascular composite events in adults with type 2 diabetes on semaglutide in the SUSTAIN-6 trialSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • -14.9%Mean weight change on semaglutide 2.4 mg weekly in adults without diabetes (STEP 1, Wegovy dose)Source: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026

See the public record for Semaglutide

At a glance

  • Drug / Ozempic (semaglutide), once-weekly injection
  • Labeled uses / Type 2 diabetes; CV risk reduction with established CV disease; kidney outcomes with CKD [1]
  • Weight-loss indication / None on the Ozempic label [1]
  • Weight-management semaglutide / Wegovy [2]
  • First approved / 2017-12-05, NDA 209637 [3]
  • Dosing / 0.25 mg weekly for 4 weeks, then 0.5 mg; maintenance 0.5, 1 or 2 mg [1]
  • Ask your plan / Drug-list status, tier, prior authorization, step therapy

What Ozempic is approved to treat

Ozempic is a GLP-1 receptor agonist taken as a once-weekly semaglutide injection. Its label lists three uses, all in adults with type 2 diabetes [1]:

  • Improve blood sugar control, alongside diet and exercise.
  • Reduce the risk of major cardiovascular events (cardiovascular death, non-fatal heart attack, non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease.
  • Reduce the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.

Weight loss is not one of them, and safety and efficacy have not been established in pediatric patients [1].

The FLOW trial randomized 3,533 adults with type 2 diabetes and chronic kidney disease to Ozempic 1 mg weekly or placebo. Over a median of 3.4 years, the composite of kidney failure, at least 50% eGFR decline, or kidney or cardiovascular death occurred in 18.7% versus 23.2% (HR 0.76) [6]. In SUSTAIN-6, 3,297 adults with type 2 diabetes were randomized to semaglutide 0.5 or 1 mg or placebo for 104 weeks; the cardiovascular composite occurred in 6.6% versus 8.9% (HR 0.74) [7].

If weight loss is the goal, a different product carries that label

Wegovy is the semaglutide product FDA-approved for weight reduction, in adults with obesity or with overweight plus at least one weight-related condition, and in children 12 and older with obesity [2]. Ozempic and Wegovy are separate approvals with separate labels [3][8]. In STEP 1, 1,961 adults with a BMI of 30 or more, or 27 or more with a weight-related condition, and no diabetes took semaglutide 2.4 mg weekly or placebo for 68 weeks; mean weight change was -14.9% versus -2.4% [9]. Ozempic itself has no weight-loss indication [1].

Questions to ask about your plan

Coverage depends on the plan, so these questions are the practical way to find out:

  • Is Ozempic on the drug list for my exact plan ID?
  • What tier is it on, and is cost sharing a flat copay or coinsurance?
  • Does my plan require prior authorization for Ozempic?
  • Does my plan require trying another drug first?

The label's indications require type 2 diabetes. The cardiovascular indication also requires established cardiovascular disease, and the kidney indication requires chronic kidney disease [1].

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. According to the article, is weight loss one of the labeled uses for Ozempic?

Question 1 of 5

Score: 0 right, 0 of 5 answered

What people on Reddit report

Accounts from people dealing with Anthem over Ozempic or Wegovy, covering denials, prior authorization, plan changes, and weight-loss exclusions.

Affectionate_Ask7788 · Ozempic

Anthem is denying my Rx with the excuse that Ozempic has only been approved by the FDA for type 2 diabetes.

Anthem denied the poster's Ozempic prescription, citing the diabetes-only approval, even though the poster had weight-related risk factors.

Read the source discussion

Affectionate_Ask7788 · Ozempic

Anthem doesn't cover Wegovy for weight loss. It only covers the amphetamine-type drugs.

A commenter says their Anthem plan did not cover Wegovy for weight loss.

Read the source discussion

Pall_Bearmasher · HealthInsurance

I was prescribed ozempic because I am type 2 diabetic and it was covered by my insurance for roughly 3 months then the pharmacy had trouble filling orders.

The poster's Ozempic was covered at first, then Anthem required prior authorization and later stopped covering it.

Read the source discussion

Apprehensive_Pie4771 · HealthInsurance

I've had Ozempic covered then not covered again. It's super frustrating.

A commenter says Ozempic coverage changed from one plan year to the next, so they had to check each plan's formulary.

Read the source discussion

Questions worth asking

Choose the questions you want to keep

Frequently asked questions

Is Ozempic FDA-approved for weight loss?
No. Ozempic is approved for type 2 diabetes: blood sugar control, cardiovascular risk reduction in adults with type 2 diabetes and established cardiovascular disease, and kidney risk reduction in adults with type 2 diabetes and chronic kidney disease [1]. Wegovy is the semaglutide product approved for weight reduction [2].
Are Ozempic and Wegovy different products?
Yes. They are separate FDA approvals with separate labels [3][8]. Ozempic is labeled for type 2 diabetes [1]. Wegovy is approved for weight reduction in adults with obesity, or overweight plus at least one weight-related condition, and in children 12 and older with obesity [2]. In STEP 1, 1,961 adults without diabetes had a mean weight change of -14.9% on semaglutide 2.4 mg weekly versus -2.4% on placebo over 68 weeks [9].
What medical conditions match Ozempic's labeled uses?
Ozempic's labeled uses beyond blood-sugar control are reducing major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and reducing certain kidney and cardiovascular outcomes in adults with type 2 diabetes and chronic kidney disease [1]. The label says Ozempic is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2 [1].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

Does Anthem BCBS cover GLP-1?

This article cannot confirm whether Anthem covers Ozempic or other GLP-1 medications, because coverage depends on your specific plan. To find out, check whether Ozempic is on the drug list for your exact plan ID, what tier it sits on, and whether it requires prior authorization or trying another drug first.

Will Anthem pay for Ozempic for weight loss?

Ozempic has no weight-loss indication on its label, so it is not approved for weight loss. Wegovy is the semaglutide product FDA-approved for weight reduction, in adults with obesity or overweight plus at least one weight-related condition, and in children 12 and older with obesity. Whether Anthem pays for either depends on your specific plan.

Is this a hard no?

No. Coverage depends on your specific plan, and the status of no Anthem plan can be confirmed from the information available. Ozempic is labeled for type 2 diabetes and has no weight-loss indication, so your plan's drug list, tier, and prior authorization rules decide whether it is covered.

References

Show all 11 referencesHide references
  1. U.S. National Library of Medicine, DailyMed. Ozempic injection prescribing information. Ozempic injection label
  2. FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications | FDA.
  3. Drugs@FDA: FDA-Approved Drugs.
  4. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA.
  5. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDA.
  6. Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med. 2024;391(2):109-121.
  7. Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016;375(19):1834-1844.
  8. Drugs@FDA: FDA-Approved Drugs.
  9. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
  10. Reddit participants. Help getting Ozempic covered by insurance (Anthem/Optum Rx) (r/Ozempic). Accessed 2026-11-10.
  11. Reddit participants. Anyone have experience with Anthem Blucross Blue Shield? (r/HealthInsurance). Accessed 2026-11-10.
Does anthem cover ozempic: evidence summary chart
Image: HealthRX.com. Full does anthem cover ozempic guide and sources at healthrx.com/glp-1-faq.